In vivo temporal control of activatable matrixdegrading enzymes

Details for Australian Patent Application No. 2009220094 (hide)

Owner Halozyme, Inc.

Inventors Keller, Gilbert A.; Frost, Gregory I.

Agent Pizzeys

Pub. Number AU-A-2009220094

PCT Pub. Number WO2009/111083

Priority 61/127,725 14.05.08 US; 61/068,667 06.03.08 US

Filing date 6 March 2009

Wipo publication date 11 September 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

19 August 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read In vivo temporal control of activatable matrixdegrading enzymes 2010

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/111083 Priority application(s): WO2009/111083

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220105-Wire guide for an automatic staple gun

2009220087-Recovery of rhenium from a rheniumcontaining titania catalyst